{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:03:40Z","timestamp":1791482620086,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.yrtph.2006.05.004","type":"journal-article","created":{"date-parts":[[2006,7,4]],"date-time":"2006-07-04T20:27:15Z","timestamp":1152044835000},"page":"273-281","source":"Crossref","is-referenced-by-count":18,"title":["Evaluation of the toxic potentials of a new camptothecin anticancer agent CKD-602 on fertility and early embryonic development in rats"],"prefix":"10.1016","volume":"45","author":[{"given":"Moon-Koo","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Seop","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Choon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2006.05.004_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0300-483X(99)00056-6","article-title":"Multivariate statistical analysis of organ weights in toxicity studies","volume":"136","author":"Andersen","year":"1999","journal-title":"Toxicology"},{"key":"10.1016\/j.yrtph.2006.05.004_bib2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1080\/01926230490465874","article-title":"Relationships between organ weight and body\/brain weight in the rat: what is the best analytical endpoint?","volume":"32","author":"Bailey","year":"2004","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2006.05.004_bib3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1098\/rspa.1937.0109","article-title":"Properties of sufficiency and statistical test","volume":"160","author":"Bartlett","year":"1937","journal-title":"Proc. R. Soc. Lond. Series A"},{"key":"10.1016\/j.yrtph.2006.05.004_bib4","first-page":"1","article-title":"CPT-11: from DNA topology to clinical activity","volume":"23","author":"Bleiberg","year":"1996","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.yrtph.2006.05.004_bib5","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1073\/pnas.92.9.3726","article-title":"Molecular and cytotoxic effects of camptothecin, a topoisomerase I inhibitor, on trypanosomes and Leishmania","volume":"92","author":"Bodley","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yrtph.2006.05.004_bib6","series-title":"Pathology of the Fischer Rat. Reference and Atlas","author":"Boorman","year":"1990"},{"key":"10.1016\/j.yrtph.2006.05.004_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1023\/A:1023565227808","article-title":"Toxicity patterns of cytotoxic drugs","volume":"21","author":"Chatelut","year":"2003","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.yrtph.2006.05.004_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.reprotox.2005.01.004","article-title":"Embryotoxic effects of CKD-602, a new camptothecin anticancer agent, in rats","volume":"20","author":"Chung","year":"2005","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2006.05.004_bib9","first-page":"35","article-title":"Effects of CKD-602, a new camptothecin anticancer agent, on pregnant does and embryo-fetal development in rabbits","volume":"28","author":"Chung","year":"2005","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2006.05.004_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1745-7262.2005.00007.x","article-title":"Evaluation of spermatogenesis and fertility in F1 male rats after in utero and neonatal exposure to ELF electromagnetic fields","volume":"7","author":"Chung","year":"2005","journal-title":"Asian J. Androl."},{"key":"10.1016\/j.yrtph.2006.05.004_bib11","first-page":"1455","article-title":"CKD-602. Chong Kun Dang","volume":"4","author":"Crul","year":"2003","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.yrtph.2006.05.004_bib12","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1200\/JCO.1996.14.4.1236","article-title":"Phase I and pharmacokinetic study of 9-aminocamptothecin given as a 72-hour infusion in adult cancer patients","volume":"14","author":"Dahut","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.yrtph.2006.05.004_bib13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/019262301301418874","article-title":"Reproductive endocrinology and toxicological pathology over the life span of the female rodent","volume":"29","author":"Davis","year":"2001","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2006.05.004_bib14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2307\/2528490","article-title":"New tables for multiple comparisons with a control","volume":"20","author":"Dunnett","year":"1964","journal-title":"Biometrics"},{"key":"10.1016\/j.yrtph.2006.05.004_bib15","series-title":"Statistical Methods for Research Workers","author":"Fisher","year":"1970"},{"key":"10.1016\/j.yrtph.2006.05.004_bib16","first-page":"461","article-title":"Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC 100880)","volume":"54","author":"Gottlieb","year":"1970","journal-title":"Cancer Chemother. Rep."},{"key":"10.1016\/j.yrtph.2006.05.004_bib17","series-title":"Histopathology of Preclinical Studies: Interpretation and Relevance in Drug Evaluation","author":"Greaves","year":"1990"},{"key":"10.1016\/j.yrtph.2006.05.004_bib18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2165\/00002018-200629030-00005","article-title":"Camptothecin and podophyllotoxin derivatives: inhibitors of topoisomerase I and II\u2014Mechanisms of action, pharmacokinetics and toxicity profile","volume":"29","author":"Hartmann","year":"2006","journal-title":"Drug Saf."},{"key":"10.1016\/j.yrtph.2006.05.004_bib19","series-title":"Fundamentals of Toxicologic Pathology","author":"Haschek","year":"1998"},{"key":"10.1016\/j.yrtph.2006.05.004_bib20","first-page":"369","article-title":"Mutagenic activity of topoisomerase I inhibitors","volume":"1","author":"Hashimoto","year":"1995","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yrtph.2006.05.004_bib21","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1021\/jm00123a038","article-title":"Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity","volume":"32","author":"Hertzberg","year":"1989","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.yrtph.2006.05.004_bib22","first-page":"90","article-title":"Reproduction and developmental toxicity studies of CPT-11: study on administration of the test substance prior to and in the early stages of pregnancy in rats","volume":"24","author":"Itabashi","year":"1990","journal-title":"Clin. Rep."},{"key":"10.1016\/j.yrtph.2006.05.004_bib23","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/S0278-6915(02)00152-7","article-title":"Subchronic toxicity of plant sterol esters administered by gavage to Sprague\u2013Dawley rats","volume":"40","author":"Kim","year":"2002","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2006.05.004_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.tox.2003.11.006","article-title":"Effects of prenatal exposure to the environmental pollutant 2-bromopropane on embryo-fetal development in rats","volume":"196","author":"Kim","year":"2004","journal-title":"Toxicology"},{"key":"10.1016\/j.yrtph.2006.05.004_bib25","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0278-6915(02)00325-3","article-title":"26-Week repeated oral dose toxicity study of the new quinolone antibacterial DW-116 in Sprague\u2013Dawley rats","volume":"41","author":"Kim","year":"2003","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2006.05.004_bib26","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.yrtph.2004.09.002","article-title":"Subacute toxicity evaluation of a new camptothecin anticancer agent CKD-602 administered by intravenous injection to rats","volume":"40","author":"Kim","year":"2004","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2006.05.004_bib27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.fct.2004.12.020","article-title":"4-Week repeated intravenous dose toxicity study of a new camptothecin anticancer agent CKD-602 in dogs","volume":"43","author":"Kim","year":"2005","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2006.05.004_bib28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0378-5173(02)00099-6","article-title":"Preformulation studies of a novel camptothecin anticancer agent, CKD-602: physicochemical characterization and hydrolytic equilibrium kinetics","volume":"239","author":"Kim","year":"2002","journal-title":"Int. J. Pharmacol."},{"key":"10.1016\/j.yrtph.2006.05.004_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000011923","article-title":"Topotecan\u2014a novel topoisomerase I inhibitor: pharmacology and clinical experience","volume":"56","author":"Kolimannsberger","year":"1999","journal-title":"Oncology"},{"key":"10.1016\/j.yrtph.2006.05.004_bib30","first-page":"99","article-title":"Topoisomerase I interactive agents","volume":"20","author":"Kirstein","year":"2002","journal-title":"Cancer Chemother. Biol. Response Modif."},{"key":"10.1016\/j.yrtph.2006.05.004_bib31","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2307\/2280779","article-title":"Use of ranks in one criterion variance analysis","volume":"47","author":"Kruskal","year":"1952","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.yrtph.2006.05.004_bib32","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF02975379","article-title":"Antitumor activity of 7-[2-(N-isopropylamino)ethyl]-(20S)-camptothecin, CKD602, as a potent DNA topoisomerase I inhibitor","volume":"21","author":"Lee","year":"1998","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.yrtph.2006.05.004_bib33","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1749-6632.2000.tb07055.x","article-title":"Preclinical and phase I clinical studies with CKD-602, a novel camptothecin derivative","volume":"922","author":"Lee","year":"2000","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.yrtph.2006.05.004_bib34","first-page":"95","article-title":"Phase II study of camptothecin (NSC 100880) in the treatment of advanced gastrointestinal cancer","volume":"56","author":"Moertel","year":"1972","journal-title":"Cancer Chemother. Rep."},{"key":"10.1016\/j.yrtph.2006.05.004_bib35","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0272-0590(88)90159-5","article-title":"Evaluation of rodent sperm, vaginal cytology, and reproductive organ weight data from national toxicology program 13-week studies","volume":"11","author":"Morrissey","year":"1988","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2006.05.004_bib36","unstructured":"NRC (National Research Council), 1996. Guide for the Care and Use of Laboratory Animals. National Research Council. National Academy, Washington, USA."},{"key":"10.1016\/j.yrtph.2006.05.004_bib37","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/BF02976950","article-title":"In vitro pharmacodynamics of CKD-602 in HT-29 cells","volume":"25","author":"Park","year":"2002","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.yrtph.2006.05.004_bib38","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(03)13780-4","article-title":"The camptothecins","volume":"361","author":"Pizzolato","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.yrtph.2006.05.004_bib39","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1023\/A:1008270717294","article-title":"Topoisomerase I inhibitors: review and update","volume":"8","author":"Rothenberg","year":"1997","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.yrtph.2006.05.004_bib40","unstructured":"SAS Institute, Inc., 1997. SAS\/STAT Software: Changes and Enhancements Through Release 6.12. SAS Institute, NC, USA."},{"key":"10.1016\/j.yrtph.2006.05.004_bib41","first-page":"87","article-title":"A method of judging all contrasts in the analysis of variance","volume":"40","author":"Scheffe","year":"1953","journal-title":"Biometika"},{"key":"10.1016\/j.yrtph.2006.05.004_bib42","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/jnci\/85.4.271","article-title":"The current status of camptothecin analogues as antitumor agents","volume":"85","author":"Slichenmyer","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.yrtph.2006.05.004_bib43","doi-asserted-by":"crossref","first-page":"15387","DOI":"10.1073\/pnas.242259599","article-title":"The mechanism of topoisomerase I poisoning by a camptothecin analog","volume":"99","author":"Staker","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yrtph.2006.05.004_bib44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0167-4781(98)00130-4","article-title":"Clinical applications of the camptothecins","volume":"1400","author":"Takimoto","year":"1998","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230006000894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230006000894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T19:58:31Z","timestamp":1555703911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230006000894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0273230006000894"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2006.05.004","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}